3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
6
Uterine Cervical Dysplasia
4
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Colorectal Neoplasms
1
Barrett Esophagus
1
Acquired Immunodeficiency Syndrome
1
Interventions
Human Papillomavirus DNA Tests
6
Colposcopy
6
Educational Status
5
Specimen Handling
4
Early Intervention, Educational
4
Vaginal Smears
3
Surveys and Questionnaires
3
Patient Navigation
3
Methods
3
epigallocatechin gallate
2
Vitamin B 12
2
Transurethral Resection of Prostate
2
Standard of Care
2
Practice Guidelines as Topic
2
Motivational Interviewing
2
Mass Screening
2
Electrocoagulation
2
Watchful Waiting
1
Triage
1
Telemedicine
1
Standing Orders
1
Referral and Consultation
1
Radiotherapy, Intensity-Modulated
1
Pregnancy Tests
1
Papanicolaou Test
1
Nimorazole
1
Mindfulness-Based Stress Reduction
1
Lacteol
1
Interviews as Topic
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Papillomavirus Infections
×
Acetic Acid
×
Clear all
NCT07240220
2026-01-15
Merck-4
Indiana University
Phase NA
Not yet recruiting
2,500 enrolled